论文信息 - Intranasal vaccination with a lipopeptide containing a minimal, conserved M-protein derived peptide and a self-adjuvanting lipid induces both systemic and mucosal immune responses in mice - 字舞流文

Intranasal vaccination with a lipopeptide containing a minimal, conserved M-protein derived peptide and a self-adjuvanting lipid induces both systemic and mucosal immune responses in mice

D. Jackson | W. Zeng | M. Batzloff | M. Good | J. Hartas

[1] M. Davies,et al. Toward the development of an antidisease, transmission-blocking intranasal vaccine for group a streptococcus. , 2005, The Journal of infectious diseases.

[2] Corey Smith,et al. A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[3] L. BenMohamed,et al. Systemic immune responses induced by mucosal administration of lipopeptides without adjuvant , 2002, European journal of immunology.

[4] M. Cunningham,et al. Pathogenesis of group A streptococcal infections. , 2000, Clinical microbiology reviews.

[5] L. BenMohamed,et al. High immunogenicity in chimpanzees of peptides and lipopeptides derived from four new Plasmodium falciparum pre-erythrocytic molecules. , 2000, Vaccine.

[6] M. Good,et al. Mapping the minimal murine T cell and B cell epitopes within a peptide vaccine candidate from the conserved region of the M protein of group A streptococcus. , 1997, International immunology.

[7] V. Fischetti,et al. Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci , 1988, Infection and immunity.

[8] P. Brandtzaeg. Role of secretory antibodies in the defence against infections. , 2003, International journal of medical microbiology : IJMM.